Osaka, Japan

Yasuyoshi Iso




Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yasuyoshi Iso: Innovator in Pharmaceutical Chemistry

Introduction

Yasuyoshi Iso is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on developing innovative compounds that address various medical conditions.

Latest Patents

Among his latest patents, Yasuyoshi Iso has developed heterocyclic compounds that relate to compounds of Formula I. These compounds and their pharmaceutically acceptable derivatives are designed for treating or preventing conditions such as pain, urinary incontinence, ulcers, inflammatory bowel disease, and irritable bowel syndrome. Another notable patent involves pyridone derivatives that exhibit binding activity to the cannabinoid type 2 receptor. This compound is represented by a specific formula that includes various groups and substitutions, showcasing his expertise in medicinal chemistry.

Career Highlights

Throughout his career, Yasuyoshi Iso has worked with reputable companies, including Shionogi & Company Limited and Purdue Pharma L.P. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Yasuyoshi Iso has collaborated with notable colleagues such as Yukio Tada and Kohji Hanasaki. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Yasuyoshi Iso's innovative work in pharmaceutical chemistry has led to the development of valuable compounds that address critical health issues. His contributions continue to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…